ACAD9
Basic information
Region (hg38): 3:128879596-128924003
Links
Phenotypes
GenCC
Source:
- acyl-CoA dehydrogenase 9 deficiency (Definitive), mode of inheritance: AR
- acyl-CoA dehydrogenase 9 deficiency (Strong), mode of inheritance: AR
- acyl-CoA dehydrogenase 9 deficiency (Strong), mode of inheritance: AR
- acyl-CoA dehydrogenase 9 deficiency (Supportive), mode of inheritance: AR
- acyl-CoA dehydrogenase 9 deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Mitochondrial complex I deficiency, nuclear type 20 | AR | Biochemical | Individuals may present early in life with findings including neurologic abnormalities, cardiomyopathy, and lactic acidosis, and early institution of medical treatment (eg, with riboflavin) has been reported as leading to marked decreases in morbidity/mortality | Biochemical; Cardiovascular; Gastrointestinal; Musculoskeletal; Neurologic | 17564966; 21057504; 20929961; 21057504; 22499348; 25721401 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (877 variants)
- Acyl-CoA_dehydrogenase_9_deficiency (268 variants)
- Inborn_genetic_diseases (80 variants)
- not_specified (47 variants)
- ACAD9-related_disorder (32 variants)
- Mitochondrial_complex_I_deficiency (16 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ACAD9 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000014049.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | 293 | 308 | |||
missense | 41 | 218 | 26 | 288 | ||
nonsense | 11 | 13 | 24 | |||
start loss | 3 | 1 | 4 | |||
frameshift | 28 | 48 | 76 | |||
splice donor/acceptor (+/-2bp) | 51 | 54 | ||||
Total | 47 | 153 | 231 | 319 | 4 |
Highest pathogenic variant AF is 0.000726067
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ACAD9 | protein_coding | protein_coding | ENST00000308982 | 18 | 36472 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.53e-8 | 0.990 | 125677 | 0 | 71 | 125748 | 0.000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.179 | 367 | 357 | 1.03 | 0.0000224 | 4054 |
Missense in Polyphen | 118 | 131.93 | 0.89441 | 1430 | ||
Synonymous | -0.170 | 147 | 144 | 1.02 | 0.00000954 | 1240 |
Loss of Function | 2.37 | 17 | 31.3 | 0.543 | 0.00000155 | 379 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000832 | 0.000829 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000257 | 0.000255 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000262 | 0.000261 |
Other | 0.000656 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Required for mitochondrial complex I assembly (PubMed:20816094, PubMed:24158852). Has a dehydrogenase activity on palmitoyl-CoA (C16:0) and stearoyl-CoA (C18:0). It is three times more active on palmitoyl-CoA than on stearoyl-CoA. However, it does not play a primary role in long-chain fatty acid oxidation in vivo (PubMed:20816094, PubMed:24158852). Has little activity on octanoyl-CoA (C8:0), butyryl-CoA (C4:0) or isovaleryl-CoA (5:0). {ECO:0000269|PubMed:20816094, ECO:0000269|PubMed:24158852}.;
- Pathway
- Respiratory electron transport;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;Complex I biogenesis;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
(Consensus)
Recessive Scores
- pRec
- 0.223
Intolerance Scores
- loftool
- 0.168
- rvis_EVS
- -0.84
- rvis_percentile_EVS
- 11.36
Haploinsufficiency Scores
- pHI
- 0.104
- hipred
- N
- hipred_score
- 0.492
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.999
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Acad9
- Phenotype
Gene ontology
- Biological process
- long-chain fatty acid metabolic process;mitochondrial respiratory chain complex I assembly;medium-chain fatty acid metabolic process;oxidation-reduction process
- Cellular component
- nucleus;mitochondrion;mitochondrial inner membrane;dendrite;mitochondrial membrane
- Molecular function
- fatty-acyl-CoA binding;long-chain-acyl-CoA dehydrogenase activity;protein binding;very-long-chain-acyl-CoA dehydrogenase activity;flavin adenine dinucleotide binding;medium-chain-acyl-CoA dehydrogenase activity